Prodrome
Early warning signs such as fatigue, neck stiffness, and light sensitivity.
In pivotal clinical studies, some people had pain freedom within 2 hours.
In another study with people who could reliably predict
a headache before it began, 46% avoided intense head
pain through 24 hours (vs 29% on placebo).
See below for more information.*
The early signs of a migraine attack can start hours before head pain hits. These early signs, which may be part of the prodrome phase, are your body's way of warning you that head pain may begin. By understanding these signs, you can learn to recognize and treat your migraine attacks earlier and possibly avoid head pain before it begins.
77%
of people reported experiencing prodrome symptoms before their headache.†
46%
who took UBRELVY 100 mg avoided moderate to severe head pain through 24 hours vs 29% on placebo.
2X
more likely to avoid intense head pain through 24 hours than those on placebo.
*Not everyone had pre-headache symptoms; some studied couldn't accurately predict their headaches. The most common side effects were nausea, dizziness, and sleepiness.
†Within 1 to 6 hours at least 75% of the time.
Note: Not everyone has these signs, and they can differ from person to person. No conclusions can be made around the efficacy of UBRELVY for prodrome symptoms.
Early warning signs such as fatigue, neck stiffness, and light sensitivity.
You may see flashes of light, experience temporary loss of sight, or feel tingling in parts of your body.
This is when the intense, throbbing pain hits, often accompanied by nausea or vomiting.
After head pain fades, you might feel drained, confused, or washed out.
Not actual card.
‡Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit UBRELVY.com/savings-terms or call 1-844-482-7358 for more information. To learn about AbbVie's privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100
Please see full Patient Information.